Cross Country Healthcare, Inc.
HealthcareNASDAQ:CCRN · NASDAQ Global Select
-$0.02 today
Vol 0.22M · Avg 0.64M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$1.0B of revenue converted into -$98.6M of net income for the selected period. Gross margin is 19.8% and net margin is -10.3%, showing how much revenue survives after costs and taxes. EPS is $-3.05, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B -21.6% | $1.3B -33.5% | $2.0B -28.0% | $2.8B +67.2% | $1.7B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $857.5M -19.8% | $1.1B -31.8% | $1.6B -28.0% | $2.2B +67.4% | $1.3B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $196.8M -28.2% | $274.3M -39.1% | $450.4M -27.9% | $624.5M +66.5% | $375.0M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 18.7% -1.7pp | 20.4% -1.9pp | 22.3% +0.0pp | 22.3% -0.1pp | 22.4% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $200.7M -21.2% | $254.8M -19.1% | $315.0M -2.9% | $324.2M +47.3% | $220.0M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $200.2M -31.2% | $291.1M -13.8% | $337.7M -4.8% | $354.6M +50.4% | $235.7M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $16.8M -4.0% | $17.5M -4.6% | $18.3M +45.9% | $12.6M +33.1% | $9.5M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$64.5M -484.5% | $16.8M -87.0% | $129.3M -53.8% | $280.1M +81.2% | $154.6M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -6.1% -7.4pp | 1.2% -5.2pp | 6.4% -3.6pp | 10.0% +0.8pp | 9.2% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$3.5M +79.5% | -$16.9M -115.0% | $112.7M -58.2% | $269.9M +93.7% | $139.3M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -0.3% +0.9pp | -1.3% -6.8pp | 5.6% -4.0pp | 9.6% +1.3pp | 8.3% | 16.6% | 24.1% | 22.0% |
| Interest Income | $3.1M +52.6% | $2.0M | $0 -100.0% | $10.0K | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $2.2M +1.3% | $2.2M -73.0% | $8.1M -43.8% | $14.4M +109.6% | $6.9M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$80.0M -17240.9% | $467.0K +104.8% | -$9.8M +41.5% | -$16.8M -175.3% | -$6.1M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$83.5M -409.3% | -$16.4M -115.9% | $102.9M -59.3% | $253.1M +90.0% | $133.2M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -7.9% -6.7pp | -1.2% -6.3pp | 5.1% -3.9pp | 9.0% +1.1pp | 7.9% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $11.3M +715.7% | -$1.8M -106.1% | $30.3M -54.9% | $67.1M +5465.1% | $1.2M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$94.9M -551.6% | -$14.6M -120.0% | $72.6M -60.9% | $186.0M +40.9% | $132.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | -9.0% -7.9pp | -1.1% -4.7pp | 3.6% -3.0pp | 6.6% -1.2pp | 7.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$3 -565.9% | -$0 -121.3% | $2 -59.3% | $5 +41.4% | $4 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$3 -565.9% | -$0 -121.5% | $2 -59.2% | $5 +42.2% | $4 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $32.4M -2.9% | $33.4M -5.1% | $35.2M -5.0% | $37.0M +0.9% | $36.7M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $32.4M -2.9% | $33.4M -5.9% | $35.5M -5.5% | $37.5M +0.4% | $37.4M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.88B
Enhabit, Inc.
EHAB
$706.91M
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
Surmodics, Inc.
SRDX
$614.51M
The Oncology Institute, Inc.
NASDAQ:TOI
$530.91M
OrthoPediatrics Corp.
NASDAQ:KIDS
$457.71M
Charming Medical Limited Class A Ordinary Shares
MCTA
$445.55M
Auna S.A.
NYSE:AUNA
$364.93M
Treace Medical Concepts, Inc.
NASDAQ:TMCI
$263.38M
OptimizeRx Corporation
NASDAQ:OPRX
$98.14M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does CCRN generate?
Cross Country Healthcare, Inc. (CCRN) reported $1.05B of revenue in fiscal 2025.
Is CCRN profitable?
Cross Country Healthcare, Inc. (CCRN) reported -$94,852,000.00 of net income, with a net margin of -9.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.